Free Trial

Colgate-Palmolive (NYSE:CL) Holdings Decreased by Edgestream Partners L.P.

Colgate-Palmolive logo with Consumer Staples background

Edgestream Partners L.P. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 79.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 3,998 shares of the company's stock after selling 15,866 shares during the period. Edgestream Partners L.P.'s holdings in Colgate-Palmolive were worth $415,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CL. Massachusetts Financial Services Co. MA lifted its stake in Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after buying an additional 557,492 shares during the period. Legal & General Group Plc lifted its holdings in shares of Colgate-Palmolive by 0.8% during the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after purchasing an additional 61,413 shares in the last quarter. FMR LLC increased its stake in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock worth $551,367,000 after acquiring an additional 2,955,442 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Colgate-Palmolive by 0.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 4,595,245 shares of the company's stock valued at $477,032,000 after buying an additional 11,750 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a report on Monday, October 28th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective on the stock. Finally, Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Check Out Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

CL stock traded down $0.46 during midday trading on Friday, reaching $94.64. The stock had a trading volume of 1,676,800 shares, compared to its average volume of 4,372,145. The stock has a market cap of $77.32 billion, a PE ratio of 27.40, a P/E/G ratio of 3.38 and a beta of 0.43. The firm has a fifty day simple moving average of $96.73 and a two-hundred day simple moving average of $98.61. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52-week low of $75.50 and a 52-week high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

→ Did You See Trump’s Bombshell Exec. Order 001? (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines